Systematic review with meta-analysis: COVID-19 outcomes in patients receiving anti-TNF treatments.

Georgios KokkotisKonstantina KitsouIoannis XynogalasVana SpoulouGkikas MagiorkinisIoannis TrontzasPanagiotis TrontzasGaryphallia PoulakouKonstantinos SyrigosGiorgos Bamias

Published in: Alimentary pharmacology & therapeutics (2021)

TNF-α inhibitors are associated with a lower probability of hospitalisation and severe COVID-19 when compared to any other treatment for an underlying inflammatory disease.

Keyphrases

coronavirus disease
sars cov
rheumatoid arthritis
oxidative stress
respiratory syndrome coronavirus
early onset
type diabetes
adipose tissue
metabolic syndrome
skeletal muscle
insulin resistance
glycemic control
replacement therapy